NA Proactive news snapshot: Safe-T Group, Victory Square Technologies, AIM ImmunoTech, Energy Fuels UPDATE …

Safe-T Group Ltd (NASDAQ:SEFT) (TASE:SFET), a provider of secure access solutions and intelligent data collection, reported its fourth-quarter and full-year results on Monday, including 2020 revenue that jumped by nearly 50% year-over-year. The company posted revenue of $4.8 million for 2020, an increase of 49% from $3.2 million in 2019. Revenue for the three-month period ended December 31, 2020, was $1.3 million, an increase of 16% from $1.1 million in the same period a year earlier. Safe-T attributed the jump primarily to its 2019 acquisition of business proxy network solutions provider NetNut as well as an increase in IP proxy sales. Victory Square Technologies Inc (CSE:VST) (OTCMKTS:VSQTF) said Monday that its portfolio company Fantasy 360 Technologies Inc (doing business as Immersive Tech) is teaming up with celebrity YouTuber Chris Ramsay for a new immersive experience. Ramsay is a renowned magician and celebrity YouTube influencer known for performing his illusion tutorials, public illusion vlogs, and reaction videos to “bad magic” to a fanbase of 6.4 million people. Together with Immersive Tech, Ramsay will showcase the company’s UNCONTAINED experience, the world’s first pandemic-safe, free-roam AR/VR shipping container location-based entertainment franchise. AIM ImmunoTech Inc (NYSEAMERICAN:AIM) has announced that the Institutional Review Board (IRB) of Roswell Park Comprehensive Cancer Center has approved a protocol amendment to Roswell Park’s ongoing Phase 1/2a study evaluating the two-drug combination of AIM’s Ampligen and interferon alpha-2b as a potential early-onset treatment for patients with cancer and mild-to-moderate coronavirus (COVID-19). AIM ImmunoTech said the IRB-approved amendment calls for randomization of an additional 20 patients. Ten of these patients will receive a single dose of Ampligen, but no interferon treatment. The other 10 only will receive the best available care. The company noted that Ampligen alone has a generally well-tolerated safety profile with a lower risk of adverse events than is generally expected with interferon therapy. Energy Fuels Inc (NYSEAMERICAN:UUUU) (TSE:EFR) (FRA:VO51) posted 2020 financial results on Monday that saw a robust balance sheet and strong working capital of $40.2 million. For the year ended 31 December 2020, the Lakewood, Colorado-based uranium mining company, set down working capital of $40.2 million, a $19.7 million increase over the company's $20.5 million working capital at the end of December 2019. The $40.2 million included $22.4 million of cash and marketable securities, and $27.6 million of inventory, including nearly 690,700 pounds of uranium valued at $23.79 per pound, and 1,672,000 pounds of high-purity vanadium valued at $5.11 per pound. For the year, uranium production totaled around 196,500 pounds of U3O8, the most stable form of uranium oxide, and vanadium production totaled roughly 67,000 pounds of V2O5, or vanadium oxide, extensively used as a catalyst in many industrial chemical reactions. Avalon GloboCare Corp (NASDAQ:AVCO) has said it is expanding its co-development research program with the Massachusetts Institute of Technology (MIT), involving the use of CRISPR-based genome editing and QTY protein design technology to potentially treat and prevent cancer metastasis – the spreading of cancer cells from the initial tumor site to surrounding tissues and other organs. The company noted that its collaboration with MIT on the QTY code has already successfully generated a prototype device to soak up the excess chemokines and cytokines produced in the body that lead to a potentially fatal ‘cytokine storm,’ which can occur in patients with coronavirus (COVID-19) and in cancer patients being treated with CAR T-cell therapy. “This new endeavor builds on our collaboration with MIT using the QTY code technology to develop innovative therapies for cancer metastasis,” Avalon GloboCare CEO Dr David Jin said in a statement. Gevo Inc (NASDAQ:GEVO) has named industry veteran Dr Paul Bloom as its Chief Technology Officer (CTO) and Chief Innovation Officer as the company develops the renewable chemicals and materials side of its business. The Englewood, Colorado-based company noted that Dr Bloom has two decades of experience in a series of commercial and technical roles at Archer Daniels Midland Company. Most recently, Dr Bloom was the vice president of Sustainable Materials and was previously the general manager of Evolution Chemicals, where he led development and commercialization activities for the company's portfolio of renewable chemicals. In addition, Dr Bloom had global responsibility for the company's pipeline of new process technologies and partnerships with the chemical industry. Golden Minerals Company (TSE:AUM) (NYSE:AUMN) (FRA:7GB) announced over the weekend that it has begun an exploration drilling program at its operating Rodeo gold mine in Durango State in Mexico, aimed at expanding the resource.  In a statement, the Colorado-based company said the program will encompass about 2,000 meters (m) of exploration drilling at selected near-surface targets located immediately adjacent to the current pit. “The program has the potential to extend the life of the Rodeo mine well beyond the currently estimated life of around 2.5 years,” said the company. Results should begin to be available within the next several months and any newly added resources will be incorporated into the company’s production plans, it added.  Jack Nathan Medical Corp. (CVE:JNH) (OTCQB:JNHMF) said it has completed the acquisition of its 8,172 square foot flagship medical clinic located in Vaughan, Ontario within the Walmart Supercentre at 8300 Highway 27 (Woodbridge). The company, a provider of primary care medical clinics located in Walmart Supercentres under the Jack Nathan Health brand, noted that the medical centre offers a turnkey, modern clinic without start-up costs and includes all existing equipment and leasehold improvements. The new clinic is the largest in Jack Nathan Health's Walmart footprint and positions the company to grow it into a premier health services destination in York Region, Ontario. HighGold Mining Inc (CVE:HIGH) (OTCQX:HGGOF) told investors it was "extremely pleased" with regional exploration results from around the JT deposit at its 21,000 acres flagship project in Alaska, which showed widespread and diverse mineralization.  The explorer unveiled Monday rock and soil sampling assays from work carried out last year, including at the Milkbone and Easy Creek prospects. The regional program was carried out at the same time as a 32-hole drill program at the JT deposit, where HighGold already boasts a high-grade resource estimate. ImagineAR Inc (CSE:IP) (OTCQB:IPNFF) )FRA:GMS1) has partnered with First Tube Media, a branded live content innovation platform, to bring augmented reality (AR) to First Tube’s exclusive livestream programs, including episodes of the Grubhub Sound Bites concert series. The new AR capabilities will premiere with the next Sound Bites episode, featuring three-time Grammy winner Megan Thee Stallion, King Princess and Noah Cyrus on March 26, in celebration of Women's History Month. In a separate statement,  ImagineAR Inc (CSE:IP) (OTCQB:IPNFF) and Liquid Avatar Technologies Inc (CSE:LQID) (OTCMKTS:TRWRF) (FRA:4T51) reported that Oasis Digital Studios is partnering with Apex Comics Group to bring the PHAZER Universe and other published characters to Liquid Avatar as custom digital icons, integrated multi-media, Augmented Reality items and cinematic, AR-enhanced Non-Fungible Tokens (NFTs). A sneak peek of the program will be made virtually on March 26 and 27, 20301, at Comic Con International's WonderCon, ImagineAR said. Bringing images to life, ImagineAR said Oasis is developing NFTs with cinematic quality, motion, sound, and special effects that make them true collectibles. Each Oasis Cinematic and AR Enhanced NFT will come complete with an AR Experience through Liquid Avatar providing users the ability to showcase their NFTs in the virtual and real world. Idaho Champion Gold Mines Canada Inc (CSE:ITKO) (OTCQB:GLDRF) (FRA:1QB1) has revealed the final round of assay results from its 2020 diamond core drilling program at its Baner Gold Project in the producing Elk City mining district of Idaho. "The latest drill results from the Baner Project extend our mineralized corridor by more than 400%. The new intercepts at the historic BL Mine included strong gold and silver grades, which are open along strike and at depth. It is early days yet, but this new step-out to the northeast clearly warrants more work," said Idaho Champion CEO Jonathan Buick in a statement. "Baner drilling in 2020 showed us more of what we discovered in 2018. We continued to encounter near-surface gold in oxidized rocks, and this year we have seen strong gold values in sulfides as well. We had particularly good success within the central claim block, which will be a priority focus for us in the 2021 drill season." Starton Therapeutics Inc, a privately-held clinical-stage biopharmaceutical company, said its target of kicking off a Phase 1 clinical study of STAR-LLD for treating chronic lymphocytic leukemia (CLL) in the fourth quarter of 2021 remains on track. It comes after the company said it had now completed a written Type B pre-Investigational New Drug (pre-IND) meeting with the regulator, the US Food and Drug Administration (FDA). Based on the FDA’s feedback from the written response meeting, Starton will conduct a Phase 1 relative bioavailability (BA) study of STAR-LLD, a subcutaneously administered lenalidomide solution, compared to oral administration of REVLIMID in multiple myeloma patients currently receiving REVLIMID. CO2 GRO Inc (CVE:GROW) (OTCQB:BLONF) (FRA:4021) announced a commercial feasibility project of its CO2 Delivery Solutions system with Mountainview Nursery, macadamia grower in South Africa, through CO2 GRO’s South Africa-based marketing partner PharmaCrop Pty. CO2 GRO said the primary focus of the commercial feasibility project is to assess the CO2 Delivery Solutions' effects on accelerating the growth of macadamia tree seedlings in the nursery. “Our recent partnership with PharmaCrop has led to this first open-air outdoor commercial feasibility in South Africa. High-value crops grown in open-air farms are a much larger market than greenhouses that PharmaCrop is pursuing throughout South Africa,” CO2 GRO Vice President of Sales & Strategic Alliances Aaron Archibald said in a statement.  Real Luck Group Ltd (CVE:LUCK) (OTCMKTS:LCKKF), doing business as Luckbox, reported the launch of its new affiliate programme with Income Access, Paysafe Group's marketing technology and services provider. Luckbox's affiliate programme is expected to leverage Income Access platform's reporting features to make data-based marketing decisions to promote its products more effectively. Group Eleven Resources Corp (CVE:ZNG) (OTCMKTS:GRLVF) (FRA:3GE) has been encouraged by its first exploration drilling at its Gortdrum copper-silver prospect - Ireland's only modern, commercial-scale, copper mine. Gortdrum is part of the group's wholly-owned PG West project and two holes were sunk 1 kilometer (km) and 2.2km away from the former mine (mined between 1967 and 1975), along the main mineralizing structure - the "Gortdrum Fault Zone".  GlobeX Data Ltd (OTCQB:SWISF)(CSE:SWIS)(FRA:GDT), the cybersecurity and privacy solutions provider, announced that it has secured firm commitments of C$1.25 million in equity financing. The advanced technology company said each unit in the financing consists of one GlobeX Data common share priced at C$0.30 per share, and one-half of one share purchase warrant. Each full warrant will entitle the holder to purchase a share at a price of $0.50 per share for a two-year term. The offering has been fully subscribed and is now closed, said the company. GlobeX Data said the proceeds of the financing will be used to “accelerate the marketing of the company's Sekur encrypted email and messaging solution to the US market, and for general purposes.” Mind Medicine (MindMed) Inc (NEO:MMED) (OTCQB:MMEDF) (FRA:MMQ), the psychedelic medicine company, has been included in two FTSE Russell indexes, it revealed Monday.  The New York-based company was added to the FTSE Global Micro-Cap Index, which represents $1.3 trillion in global market cap, and the FTSE Total-Cap index, representing $54.7 trillion in global market cap. In a statement Monday, MindMed CEO JR Rahn called the company’s inclusion a “true honor.”  Fidelity Minerals Corp (CVE:FMN) (FRA:S5GM) (OTCMKTS:SAIDF) has announced a private placing to raise up to C$600,000 gross to advance its Peruvian exploration and community relation programs. Net proceeds of the financing will also support commercial negotiations in a bid to lift its ownership at the Las Huaquillas project, and for working capital, the project generator said Monday. The company will issue up to 4.8 million units at C$0.125 each, with each unit consisting of one share and one whole warrant.  Aurelius Minerals Inc (CVE:AUL) (OTCQB:AURQF) (FRA:1GA) announced Monday that its stock is now trading on the US-based OTCQB exchange under the symbol AURQF. "We are pleased to begin trading on the OTCQB as part of our strategy to make Aurelius shares more accessible to retail and institutional investors in the US market,” said CEO Mark Ashcroft in a statement.  “The goals of this commencement of trading through the OTCQB market are to allow access and liquidity to both U.S. and international shareholders, and to strengthen that shareholding base.” OTC Markets Group Inc. (OTCQX:OTCM), the operator of financial markets for 11,000 US and global securities, has announced that Outcrop Gold Corp. (CVE:OCG) (FRA:MRG1) (OTCQX:OCGSF), a hybrid prospect generator active in Colombia, has qualified to trade on the OTCQX Best Market and has today upgraded from the OTC Pink market. Upgrading to the OTCQX Market is an important step for companies seeking to provide transparent trading for their US investors. For companies listed on a qualified international exchange, streamlined market standards enable them to utilize their home market reporting to make their information available in the US. To qualify for OTCQX, companies must meet high financial standards, follow best practice corporate governance and demonstrate compliance with applicable securities laws. "We are pleased to commence trading on the OTCQX Market which will enhance Outcrop's visibility and provide a more efficient platform for US silver investors," commented Joe Hebert, Outcrop Gold's chief executive officer. VolitionRx Limited (NYSEAMERICAN:VNRX) has said it will be presenting at the Benzinga Biotech Small Cap Conference taking place on March 24-25, 2021.  The Benzinga Biotech Small Cap Conference bridges the gap between biotech companies, investors, and traders. Discover the companies in the biotech space who are helping to bring the world back to normalcy in the wake of the coronavirus (COVID-19) pandemic. To get a free spectator pass for the event, investors can use the following link: https://www.benzinga.com/events/small-cap/biotech/ VolitionRx Limited also announced that Scott Powell, its EVP of Investor Relations and chief financial officer of Volition America Inc., will present live at LifeSciencesInvestorForum.com on Thursday, March 25, 2021, at 11.00am ET via the following link: https://bit.ly/3qVRFyI. This will be a live, interactive online event where investors are invited to ask the company questions in real-time. If attendees are not able to join the event live on the day of the conference, and archived webcast will also be made available after the event. To learn more about the event investors can use the following link: www.lifesciencesinvestorforum.com. MagicMed Industries Inc., a biotechnology company focused on creating novel psychedelic derivative molecules, has announced that Dr Joseph Tucker, president and chief executive officer, will be presenting a business and pipeline update at the LifeSciencesInvestorForum.com on March 25, 2021, at 10.00am EST via the following link: https://bit.ly/3qVRFyI. This will be a live, interactive online event where investors are invited to ask the company questions in real-time. If attendees are not able to join the event live on the day of the conference, and archived webcast will also be made available after the event. To learn more about the event investors can use the following link: www.lifesciencesinvestorforum.com. Biocept, Inc. (NASDAQ:BIOC) has announced that it will release financial results for the three and 12 months ended December 31, 2020, after the market close on Monday, March 29, 2021. The company said it will host a conference call for the investment community to discuss the results and answer questions at 4.30pm Eastern time (1.30pm Pacific time) on Monday, March 29, 2021. Participants can pre-register for the conference call via the following link: https://dpregister.com/DiamondPassRegistration/register?confirmationNumber=10152872&linkSecurityString=e396392920. Callers who pre-register will be given a conference passcode and unique PIN to gain immediate access to the call and bypass the live operator. Participants may pre-register at any time, including up to and after the call start time. Those who choose not to pre-register can access the live conference call by dialing the following and requesting the Biocept call: US Callers: 855-656-0927; Canadian Callers 855-669-9657; Other International Callers: 412-902-4109. A live webcast of the call will be available at https://ir.biocept.com/. The webcast will be archived for 90 days. A replay of the conference call will be available for 48 hours following the conclusion of the call by dialing (877) 344-7529 for domestic callers, (855) 669-9658 for Canadian callers, or (412) 317-0088 for other international callers, and entering the replay access code 10152872. Lexaria Bioscience Corp. (NASDAQ:LEXX) (CSE:LXX) (CNSX:LXX.CN), a global innovator in drug delivery platforms, has announced that its CEO Chris Bunka is presenting at the Benzinga Biotech Small Cap Conference on March 24, 2021, at 9.45am ET. The company said Bunka will provide an overview of the company, including its DehydraTECH drug delivery technology that improves the way active pharmaceutical ingredients enter the bloodstream. He will also discuss R&D programs that have been commenced to evaluate delivery effectiveness of DehydraTECH-processed cannabidiol (CBD) for hypertension, antiviral applications for SARS diseases and other infectious diseases, as well as other strategic initiatives. Investors can register for the event using the following link:  https://events.benzinga.com/registration-page16068526119171607978331877